
HilleVax
(NASDAQ) HLVX
HilleVax Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$0.00
Net Income (TTM)
$71.10M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
HLVX News
HLVX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout HilleVax
Industry
Biotechnology
Sector
Health CareEmployees
14
CEO
Robert M. Hershberg, MD, PhD
Website
www.hillevax.comHeadquarters
Boston, MA 02109, US
HLVX Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-45%
Return on Capital
-46%
Return on Assets
-41%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$0.00
Operating Income
$155.29M
EBITDA
$155.29M
Operating Cash Flow
$108.79M
Capital Expenditure
$522.00K
Free Cash Flow
$109.31M
Cash & ST Invst.
$171.43M
Total Debt
$24.51M
HilleVax Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
+100.0%
Gross Margin
0.00%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
14
N/A
Net Income
$5.27M
+87.1%
EBITDA
$4.79M
+87.8%
Quarterly Fundamentals
Net Cash
$136.00M
-28.6%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$19.91M
-9.1%
Short Term Debt
$3.63M
-88.9%
Return on Assets
-40.65%
N/A
Return on Invested Capital
-45.70%
N/A
Free Cash Flow
$789.00K
+97.4%
Operating Cash Flow
$789.00K
+97.4%